This is a preview of subscription content, log in via an institution to check access.
Reference
Harland S, et al. Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy. European Journal of Cancer : 22 Aug 2013. Available from: URL: http://dx.doi.org/10.1016/j.ejca.2013.07.144
Additional information
* Functional Assessment of Cancer Therapy-Prostate
Rights and permissions
About this article
Cite this article
Abiraterone improves QOL for prostate cancer patients. PharmacoEcon Outcomes News 688, 10 (2013). https://doi.org/10.1007/s40274-013-0767-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0767-x